Anti-cancer activity of T-type calcium channel blocker in vivo

Bulletin of the Korean Chemical Society

Volumn 31, Issue 11, 2010, Pages 3353-3358

  Park, Hang Ah ^a   Jung, Soo Yeon ^a   Lee, So Hyung ^a   Kang, Han Byul ^a   Min, Min Sik ^a   Kim, Jungahn ^a   Choo, Dong Joon ^a   Oh, Chun Rim ^b   Kim, Young Deuk ^b   Lee, Kyung Tae ^a   Lee, Jae Yeol ^a  

^a Kyung Hee University   (South Korea)

^b DongWoo Syntech Co Ltd   (South Korea)

Author keywords

3,4 Dihydroquinazoline; A549 Xenograft; Acute toxicity; Anti cancer

Indexed keywords

3,4-DIHYDROQUINAZOLINE; A549 XENOGRAFT; ACUTE TOXICITY; ANTI-CANCER; ANTICANCER ACTIVITIES; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; DOXORUBICIN; IN-VIVO; ORAL ADMINISTRATION; TUMOR GROWTH;

ANTHROPOMETRY; TOXICITY;

BIOLOGICAL MATERIALS;

EID: 78549247910     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2010.31.11.3353     Document Type: Article

References (19)

1. Mariot, P.; Vanoverberghe, K.; Lalevee, N.; Rossier, M. F.; Prevarskaya, N. J. Biol. Chem. 2002, 277, 10824.
2. Scheiber, R. J. Membr. Biol. 2005, 205, 129.
3. Kahl, C. R.; Means, A. R. Endocr. Rev. 2003, 24, 719.
4. Lory, P.; Bidaud, I.; Chemin, J. Cell Calcium 2006, 40, 135.
5. Lang, F.; Foller, M.; Lang, K. S.; Lang, P. A.; Ritter, M.; Gulbins, E.; Vereninov, A.; Huber, S. M. J. Membr. Biol. 2005, 205, 147.
6. Bertolesi, G. E.; Shi, C.; Elbaum, L.; Jollimore, C.; Rozenberg, G.; Barnes, S.; Kelly, M. E. Mol. Pharmacol. 2002, 62, 210.
7. Lory, P.; Chemin, J. Expert Opin. Ther. Targets 2007, 11, 717 and references herein.
8. Seo, H. N.; Choi, J. Y.; Choe, Y. J.; Kim, Y.; Rhim, H.; Lee, S. H.; Kim, J.; Joo, D. J.; Lee, J. Y. Bioorg. Med. Chem. Lett. 2007, 17, 5740.
9. Heo, J. H.; Choe, Y. J.; Kim, S.; Oh, C. R.; Kim, Y. D.; Rhim, H.; Choo, D. J.; Kim, J.; Lee, J. Y. Bioorg. Med. Chem. Lett. 2008, 18, 3899.
10. Zhong, G.; Zhang. S.; Li, Y.; Liu, X.; Gao, R.; Miao, Q.; Zhen, Y. Cancer Lett. 2010, 295, 124.
11. Lee, H. S.; Ryu, J. S.; Jeon, Y. J.; Hong, Y. S.; Lee, J. J.; Hong, S. K.; Kim, T. Y. Cancer Chemother. Pharmacol. 2007, 60, 197.
12. Labonté, P.; Kadhim, S.; Bowlin, T.; Mounir, S. Hepatol. Res. 2000, 18, 72.
13. Korea Food and Drug Administration: Good Laboratory Practice, Notification No. 2005-79 (Dec. 21, 2005).
14. Korea Food and Drug Administration: The Standards of Toxicity Study for Medicinal Products, Notification No. 2005-60 (Oct. 21. 2005).
15. Tada, Y.; Fujitani, T.; Yoneyama, M. Food Chem. Toxicol. 1992, 30, 1021.
16. Sunami, S.; Ohkubo, M. Tetrahedron 2009, 65, 638.
17. Lee, D. W.; Ha, H.-J.; Lee, W. K. Synth. Commun. 2007, 37, 737.
18. Phuan, P.-W.; Kozlowski, M. C. J. Org. Chem. 2002, 67, 6339.
19. Sabot, C.; Kumar, K. A.; Meunier, S.; Mioskowski, C. Tetrahedron Lett. 2007, 48, 3863.